Bruce C. Conway

Director/Board Member at Trigemina, Inc.

72 year

Health Technology

Electronic Technology

Profile

Bruce C.
Conway is currently a Director at Trigemina, Inc. He was previously a Director at Whitehall Corp.
and an Independent Director at Clearpoint Neuro, Inc. from 2011 to 2013.

Bruce C. Conway active positions

Companies	Position	Start
Trigemina, Inc. Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA.	Director/Board Member	-

All active positions of Bruce C. Conway

Former positions of Bruce C. Conway

Companies	Position	End
CLEARPOINT NEURO, INC.	Director/Board Member	11/04/2013
Whitehall Corp. Whitehall Corp. Aerospace & DefenseElectronic Technology Part of Waste Connections, Inc., Whitehall Corp. is a private company that makes and sells marine sensing systems. The company is based in Dallas, TX. Whitehall was acquired by Aviation Sales Co. on July 31, 1998 for $103.27 million.	Director/Board Member	-

See the detail of Bruce C. Conway's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Bruce C. Conway's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
CLEARPOINT NEURO, INC.	Health Technology

Private companies	2
Whitehall Corp. Whitehall Corp. Aerospace & DefenseElectronic Technology Part of Waste Connections, Inc., Whitehall Corp. is a private company that makes and sells marine sensing systems. The company is based in Dallas, TX. Whitehall was acquired by Aviation Sales Co. on July 31, 1998 for $103.27 million.	Electronic Technology
Trigemina, Inc. Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA.	Health Technology